These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1858639)

  • 1. A critical review of the relationship between impaired fibrinolysis and myocardial infarction.
    Prins MH; Hirsh J
    Am Heart J; 1991 Aug; 122(2):545-51. PubMed ID: 1858639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between fibrinolytic function and acute myocardial infarction.
    Wiman B; Hamsten A
    Am J Cardiol; 1990 Nov; 66(16):54G-56G. PubMed ID: 2122704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.
    Prins MH; Hirsh J
    Arch Intern Med; 1991 Sep; 151(9):1721-31. PubMed ID: 1888237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
    Hamsten A; Wiman B; de Faire U; Blombäck M
    N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the fibrinolytic system in acute myocardial infarction after a normal exercise test.
    Sakata K; Kurata C; Taguchi T; Hayashi H; Kobayashi A; Yamazaki N; Rydzewski A; Takada A
    Eur Heart J; 1989 Dec; 10(12):1118-22. PubMed ID: 2514101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction.
    Pedersen OD; Munkvad S; Gram J; Kluft C; Jespersen J
    Eur Heart J; 1993 Jun; 14(6):785-9. PubMed ID: 8325306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
    Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
    Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
    Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
    Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein C inhibitor is elevated in survivors of myocardial infarction.
    Carroll VA; Griffiths MR; Geiger M; Merlo C; Furlan M; Lämmle B; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):114-8. PubMed ID: 9012645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.
    Båvenholm P; de Faire U; Landou C; Efendic S; Nilsson J; Wiman B; Hamsten A
    Eur Heart J; 1998 Mar; 19(3):402-10. PubMed ID: 9568444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factors.
    Pugh PJ; Channer KS; Parry H; Downes T; Jone TH
    Endocr Res; 2002 Aug; 28(3):161-73. PubMed ID: 12489566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.
    Gram J; Jespersen J; Kluft C; Rijken DC
    Acta Med Scand; 1987; 221(2):149-53. PubMed ID: 3591453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasminogen activator inhibitor activity in survivors of myocardial infarction is associated with metabolic risk factors of atherosclerosis.
    Keber I; Keber D
    Haemostasis; 1992; 22(4):187-94. PubMed ID: 1468721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials.
    Madan M; Halvorsen S; Di Mario C; Tan M; Westerhout CM; Cantor WJ; Le May MR; Borgia F; Piscione F; Scheller B; Armstrong PW; Fernandez-Aviles F; Sanchez PL; Graham JJ; Yan AT; Goodman SG
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):166-174. PubMed ID: 25616922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].
    González FJ; Caturla JM; Fernández M; Carrasco R; Marco P; Sánchez J; Benlloch S
    Med Intensiva; 2010 Nov; 34(8):513-22. PubMed ID: 20627371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.